The abstract notes astrocytic plaques are a CBD hallmark that rarely occurs in aging or other neurodegenerative diseases, despite CBD sharing similar cell vulnerability and transmission pathways with multiple proteinopathies. This selectivity mechanism is unexplained and could reveal disease-specific therapeutic targets. Gap type: unexplained_observation Source paper: Age-Related Pathology in Corticobasal Degeneration. (2024, International journal of molecular sciences, PMID:38473986)
Landscape Summary: Why do astrocytic plaques remain specific to CBD despite shared tau pathways with other tauopathies? is a 0.8 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
Why do astrocytic plaques remain specific to CBD despite shared tau pathways with other tauopathies? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: